Growth and profitability in small privately held biotech firms: preliminary findings

Malin Brännback; Alan Carsrud; Maija Renko; Ralf Östermark; Jaana Aaltonen; Niklas Kiviluoto

doi:10.1016/j.nbt.2009.03.006

Growth and profitability in small privately held biotech firms: preliminary findings

Malin Brännback, Alan Carsrud, Maija Renko, Ralf Östermark, Jaana Aaltonen, Niklas Kiviluoto

Tutkimustuotos: Lehtiartikkeli › Artikkeli › Tieteellinen › vertaisarvioitu

23 Sitaatiot (Scopus)

Abstrakti

This paper reports on preliminary findings on a study of the relationship of growth and profitability among small privately held Finnish Life Science firms. Previous research results concerning growth and profitability are mixed, ranging from strongly positive to a negative relationship. The conventional wisdom states that growth is a prerequisite for profitability. Our results suggest that the reverse is the case. A high profitability-low growth biotech firm is more probably to make the transition to high profitability-high growth than a firm that starts off with low profitability and high growth. © 2009 Elsevier B.V. All rights reserved.

Alkuperäiskieli	Englanti
Sivut	369-376
Sivumäärä	8
Julkaisu	New Biotechnology
Vuosikerta	25
Numero	5
DOI - pysyväislinkit	https://doi.org/10.1016/j.nbt.2009.03.006
Tila	Julkaistu - kesäk. 2009
OKM-julkaisutyyppi	A1 Julkaistu artikkeli, soviteltu

Pääsy asiakirjaan

10.1016/j.nbt.2009.03.006Lisenssi: Publisher rights policy

Muut tiedostot ja linkit

https://www.mendeley.com/catalogue/4be5cde9-b1da-3ed9-a46d-129c99b0063c/

Viittausmuodot

@article{31d54ac44108430e924f718f264f7b39,

title = "Growth and profitability in small privately held biotech firms: preliminary findings",

abstract = "This paper reports on preliminary findings on a study of the relationship of growth and profitability among small privately held Finnish Life Science firms. Previous research results concerning growth and profitability are mixed, ranging from strongly positive to a negative relationship. The conventional wisdom states that growth is a prerequisite for profitability. Our results suggest that the reverse is the case. A high profitability-low growth biotech firm is more probably to make the transition to high profitability-high growth than a firm that starts off with low profitability and high growth. {\textcopyright} 2009 Elsevier B.V. All rights reserved.",

keywords = "Biotechnology, entrepreneurship, growth entrepreneurship, profits",

author = "Malin Br{\"a}nnback and Alan Carsrud and Maija Renko and Ralf {\"O}stermark and Jaana Aaltonen and Niklas Kiviluoto",

year = "2009",

month = jun,

doi = "10.1016/j.nbt.2009.03.006",

language = "English",

volume = "25",

pages = "369--376",

journal = "New Biotechnology",

issn = "1871-6784",

publisher = "Elsevier",

number = "5",

}

TY - JOUR

T1 - Growth and profitability in small privately held biotech firms: preliminary findings

AU - Brännback, Malin

AU - Carsrud, Alan

AU - Renko, Maija

AU - Östermark, Ralf

AU - Aaltonen, Jaana

AU - Kiviluoto, Niklas

PY - 2009/6

Y1 - 2009/6

N2 - This paper reports on preliminary findings on a study of the relationship of growth and profitability among small privately held Finnish Life Science firms. Previous research results concerning growth and profitability are mixed, ranging from strongly positive to a negative relationship. The conventional wisdom states that growth is a prerequisite for profitability. Our results suggest that the reverse is the case. A high profitability-low growth biotech firm is more probably to make the transition to high profitability-high growth than a firm that starts off with low profitability and high growth. © 2009 Elsevier B.V. All rights reserved.

AB - This paper reports on preliminary findings on a study of the relationship of growth and profitability among small privately held Finnish Life Science firms. Previous research results concerning growth and profitability are mixed, ranging from strongly positive to a negative relationship. The conventional wisdom states that growth is a prerequisite for profitability. Our results suggest that the reverse is the case. A high profitability-low growth biotech firm is more probably to make the transition to high profitability-high growth than a firm that starts off with low profitability and high growth. © 2009 Elsevier B.V. All rights reserved.

KW - Biotechnology

KW - entrepreneurship

KW - growth entrepreneurship

KW - profits

UR - https://www.mendeley.com/catalogue/4be5cde9-b1da-3ed9-a46d-129c99b0063c/

U2 - 10.1016/j.nbt.2009.03.006

DO - 10.1016/j.nbt.2009.03.006

M3 - Article

C2 - 19491050

SN - 1871-6784

VL - 25

SP - 369

EP - 376

JO - New Biotechnology

JF - New Biotechnology

IS - 5

ER -

Growth and profitability in small privately held biotech firms: preliminary findings

Abstrakti

Pääsy asiakirjaan

Muut tiedostot ja linkit

Sormenjälki

Viittausmuodot